Dore GJ - Search Results

1

Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study.

Cunningham EB, Hajarizadeh B, Amin J, Bretana N, Dore GJ, Degenhardt L, Larney S, Luciani F, Lloyd AR, Grebely J; HITS-p Investigators. Cunningham EB, et al. Among authors: dore gj. Int J Drug Policy. 2018 Apr;54:18-25. doi: 10.1016/j.drugpo.2017.12.013. Epub 2018 Jan 24. Int J Drug Policy. 2018. PMID: 29367011

2

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Freeman AJ, Dore GJ, Law MG, Thorpe M, Von Overbeck J, Lloyd AR, Marinos G, Kaldor JM. Freeman AJ, et al. Among authors: dore gj. Hepatology. 2001 Oct;34(4 Pt 1):809-16. doi: 10.1053/jhep.2001.27831. Hepatology. 2001. PMID: 11584380

3

HIV and hepatitis C coinfection within the CAESAR study.

Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. Amin J, et al. Among authors: dore gj. HIV Med. 2004 May;5(3):174-9. doi: 10.1111/j.1468-1293.2004.00207.x. HIV Med. 2004. PMID: 15139984 Free article. Clinical Trial.

4

Clearance of hepatitis C virus after newly acquired infection in injection drug users.

Jauncey M, Micallef JM, Gilmour S, Amin J, White PA, Rawlinson W, Kaldor JM, van Beek I, Dore GJ. Jauncey M, et al. Among authors: dore gj. J Infect Dis. 2004 Oct 1;190(7):1270-4. doi: 10.1086/423943. Epub 2004 Aug 18. J Infect Dis. 2004. PMID: 15346337

5

The impact of injecting drug use status on hepatitis C-related referral and treatment.

Stoové MA, Gifford SM, Dore GJ. Stoové MA, et al. Among authors: dore gj. Drug Alcohol Depend. 2005 Jan 7;77(1):81-6. doi: 10.1016/j.drugalcdep.2004.07.002. Drug Alcohol Depend. 2005. PMID: 15607844

6

Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.

Hallinan R, Byrne A, Amin J, Dore GJ. Hallinan R, et al. Among authors: dore gj. Aust N Z J Public Health. 2004 Dec;28(6):576-8. doi: 10.1111/j.1467-842x.2004.tb00050.x. Aust N Z J Public Health. 2004. PMID: 15707209 Free article.

7

Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.

Hallinan R, Byrne A, Amin J, Dore GJ. Hallinan R, et al. Among authors: dore gj. J Gastroenterol Hepatol. 2005 Jul;20(7):1082-6. doi: 10.1111/j.1440-1746.2005.03882.x. J Gastroenterol Hepatol. 2005. PMID: 15955218

8

Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.

Amin J, Dore GJ, O'Connell DL, Bartlett M, Tracey E, Kaldor JM, Law MG. Amin J, et al. Among authors: dore gj. J Hepatol. 2006 Aug;45(2):197-203. doi: 10.1016/j.jhep.2006.02.014. Epub 2006 Mar 31. J Hepatol. 2006. PMID: 16684579

9

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.

Amin J, Law MG, Micallef J, Jauncey M, Van Beek I, Kaldor JM, Dore GJ. Amin J, et al. Among authors: dore gj. Epidemiol Infect. 2007 Jan;135(1):144-50. doi: 10.1017/S0950268806006388. Epub 2006 May 17. Epidemiol Infect. 2007. PMID: 16707030 Free PMC article.

10

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.

Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Amin J, et al. Among authors: dore gj. Lancet. 2006 Sep 9;368(9539):938-45. doi: 10.1016/S0140-6736(06)69374-4. Lancet. 2006. PMID: 16962883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

527 results

Search Page

Filters